http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0667156-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 1995-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed2c6c9ba75da7437ab002b742b3beda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853791cfbd45ed8422f5c1d90822131b |
| publicationDate | 1995-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0667156-A1 |
| titleOfInvention | Ophthalmic composition containing a 1,5-benzoxathiepine derivative for treating glaucoma |
| abstract | An ophthalmic composition comprising a compound of the formulan wherein R 1 and R 2 are each a hydrogen, a halogen, a hydroxyl, a lower alkyl or a lower alkoxy, R 3 and R 4 are each a hydrogen, an optionally substituted lower alkyl, an optionally substituted cycloalkyl or an optionally substituted aralkyl, or form, together with the adjacent nitrogen atom, an optionally substituted ring, X is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally esterified or amidized carboxyl, Y is >C=O or >CH-OR 5 wherein R 5 is a hydrogen, an acyl or an optionally substituted carbamoyl, m is an integer of from 0 to 2, and n is an integer of from 1 to 6, or a salt thereof, and a method for the prevention and treatment of eye diseases, comprising administering said compound or a salt thereof. |
| priorityDate | 1994-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 623.